XML 87 R46.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Sale of Stock by Activity Program
Forward sale activity under the 2020, 2022 and 2024 ATM Programs is summarized as follows ($ in millions except per share data; shares in thousands):
Contractual Maturity DatesExecution Date
Number of Shares (1)
Weighted Average Price per Share (2)
Settlement Value (2)
Outstanding, December 31, 2022February 2023 to November 2023458 $657.75 $302 
Forward Sale Agreements ExecutedFebruary 2024 to December 2024May 2023 to December 20231,208 767.12 926 
Forward Sale Shares Physically SettledFebruary 2023 to March 2024February 2023 to November 2023(1,023)718.59 735 
Outstanding, December 31, 2023November 2024643 $776.23 $499 
Forward Sale Shares Physically SettledNovember 2024 to December 2024 September 2024(643)790.41 509 
Outstanding, December 31, 2024November 2024— $— $— 
(1)For agreements settled, the amount represents the actual number of shares issued. For agreements executed and outstanding, the amount represents the number of shares that we would issue upon physical settlement.
(2)For agreements settled, the value represents the actual weighted average settlement value, net of commissions and other offering expenses. For agreements executed and outstanding, the value represents the forward amount that we would receive upon physical settlement as of that date and will be subject to adjustments for a discount rate factor equal to a specified benchmark rate less a spread minus scheduled dividends during the terms of the agreements.
Schedule of Reserve for Authorized but Unissued Shares of Common Stock
As of December 31, 2024, we had reserved the following authorized, but unissued shares of common stock for future issuances (in thousands):
Common stock options and restricted stock units3,290 
Common stock employee purchase plans2,197 
Total5,487 
Schedule of The Maximum Exposure Losses of VIE Joint Ventures
The following table summarizes our maximum exposure to loss related to the VIE Joint Ventures as of December 31, 2024 (in millions):
VIE Joint Ventures
Equity Investment$374 
Outstanding Accounts Receivable50 
Other Receivables46 
Contract Assets125 
Loan Commitment (1)
392 
Future Equity Contribution Commitments (2)
66 
Maximum Future Payments under Debt Guarantees (3)
246 
Total $1,299 
(1)Concurrent with the closing of the AMER 2 Joint Venture, we entered into a loan agreement with the AMER 2 Joint Venture, as a lender, further discussed in Note 15.
(2)The joint ventures' partners are required to make additional equity contributions proportionately upon certain occurrences, such as a shortfall in capital necessary to complete construction or to make interest payments on their outstanding debt.
(3)In connection with our 20% equity investment in the EMEA 2 Joint Venture, we provided the lenders with our guarantees covering 20% of all payments of principal and interest due under EMEA 2 Joint Venture's credit facility agreements. A portion of the guarantees relates to our AMER 1 Joint Venture. Refer to Note 14.
The following table presents the assets and liabilities of the Indonesian VIE, which were included in other assets and other liabilities on the consolidated balance sheets as of December 31 (in millions):
Balance Sheet20242023
Cash and cash equivalents$16 $20 
Property, plant and equipment, net25 
Other
Total assets$46 $30 
Total liabilities$$
Schedule of Components of Accumulated Other Comprehensive Loss, net of Tax
The changes in accumulated other comprehensive loss, net of tax, by components are as follows (in millions):
December 31, 2021Net
Change
December 31, 2022Net
Change
December 31, 2023Net
Change
December 31, 2024
Foreign currency translation adjustment ("CTA") gain (loss)
$(1,068)$(770)$(1,838)$250 $(1,588)$(772)$(2,360)
Unrealized gain (loss) on cash flow hedges (1)
(6)40 34 (19)15 32 47 
Net investment hedge CTA gain (loss) (1)
(10)426 416 (132)284 295 579 
Net actuarial loss on defined benefit plans (2)
(1)— (1)— (1)— (1)
$(1,085)$(304)$(1,389)$99 $(1,290)$(445)$(1,735)
(1)Refer to Note 7 for a discussion of the amounts reclassified from accumulated other comprehensive loss to net income.
(2)We have two defined benefit pension plans covering all employees in two countries where such plans are mandated by law. We do not have any defined benefit plans in any other countries.
Schedule of Quarterly Dividend and Special Distributions
During the years ended December 31, 2024, 2023 and 2022, our Board of Directors declared quarterly dividends whose treatment for federal income tax purposes were as follows:
Declaration DateRecord DatePayment Date
Total Distribution (1)
Nonqualified Ordinary Dividend (2)
Total Distribution Amount
(per share)(in millions)
Fiscal 2024
2/14/20242/28/20243/20/2024$4.260000 $4.260000 $402 
5/8/20245/22/20246/19/20244.260000 4.260000 405 
8/7/20248/21/20249/18/20244.260000 4.260000 405 
10/30/202411/13/202412/11/20244.260000 4.260000 412 
Total
$17.040000 $17.040000 $1,624 
Fiscal 2023
2/15/20233/7/20233/22/2023$3.410000 $3.410000 $319 
5/3/20235/24/20236/21/20233.410000 3.410000 319 
8/2/20238/23/20239/20/20233.410000 3.410000 319 
10/25/202311/15/202312/13/20234.260000 4.260000 402 
Total
$14.490000 $14.490000 $1,359 
Fiscal 2022
2/16/20223/7/20223/23/2022$3.100000 $3.100000 $282 
4/27/20225/18/20226/15/20223.100000 3.100000 282 
7/27/20228/17/20229/21/20223.100000 3.100000 286 
11/2/202211/16/202212/14/20223.100000 3.100000 287 
Total
$12.400000 $12.400000 $1,137 
(1)Common stock dividends are characterized for federal income tax purposes as nonqualified ordinary dividend, qualified ordinary dividend, capital gains or return of capital. During the years ended December 31, 2024, 2023 and 2022, we did not classify any portion of the distributions as qualified ordinary dividend, capital gains or return of capital.
(2)All nonqualified ordinary dividends are eligible for the 20% deduction generally allowable to non-corporate shareholders under Internal Revenue Code Section 199A.